ITGR
Integer Holdings Corporation
Price Chart
Latest Quote
$93.12
+1.74 (+1.90%)
Current Price
| Previous Close | $91.38 |
| Open | $92.70 |
| Day High | $94.40 |
| Day Low | $92.57 |
| Volume | 193,642 |
Stock Information
| Shares Outstanding | 33.95M |
| Total Debt | $1.38B |
| Cash Equivalents | $8.12M |
| Revenue | $1.86B |
| Net Income | $141.80M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $3.16B |
| P/E Ratio | 23.11 |
| EPS (TTM) | $4.03 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $4.54B |
| Sales | $1.86B |
| Income | $141.80M |
| Book/sh | $49.99 |
| Cash/sh | $0.24 |
| Employees | 11K |
Financial Ratios
| Quick Ratio | 2.19 |
| Current Ratio | 3.75 |
| Debt/Eq | 81.41 |
Returns & Margins
| ROA | 4.23% |
| ROE | 8.58% |
| Gross Margin | 26.81% |
| Operating Margin | 8.16% |
| Profit Margin | 7.64% |
Ownership
| Insider Ownership | 1.40% |
| Institutional Ownership | 118.51% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 13.68 |
| PEG | 2.45 |
| P/S | 1.70 |
| P/B | 1.86 |
Analyst Data
| Recommendation | none |
| Target Price | $97.56 |
Technical Indicators
| SMA20 | $91.14 |
| SMA50 | $88.92 |
| SMA200 | $85.82 |
| RSI | 51.15 |
| ATR | 2.5421 |
| Shares Float | 33.46M |
| Short Float | 16.05% |
| Short Ratio | 6.62 |
| Volatility | 0.65 |
| Rel Volume | 0.49 |
Performance History
| Week | +4.04% |
| Month | +3.31% |
| Quarter | +7.33% |
| 6 Months | +17.53% |
| YTD | +21.28% |
| Year | -22.67% |
| 3 Years | +9.05% |
| 5 Years | +0.14% |
| 10 Years | +220.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-25 | $93.12 | 193,642 |
| 2026-06-24 | $91.38 | 401,800 |
| 2026-06-23 | $89.54 | 522,800 |
| 2026-06-22 | $90.10 | 262,500 |
| 2026-06-18 | $90.96 | 581,300 |
| 2026-06-17 | $89.50 | 436,200 |
| 2026-06-16 | $91.30 | 224,700 |
| 2026-06-15 | $90.85 | 238,800 |
| 2026-06-12 | $90.98 | 225,200 |
| 2026-06-11 | $92.10 | 335,700 |
| 2026-06-10 | $91.37 | 407,700 |
| 2026-06-09 | $94.10 | 435,200 |
| 2026-06-08 | $91.89 | 216,400 |
| 2026-06-05 | $91.98 | 248,500 |
| 2026-06-04 | $92.74 | 309,900 |
| 2026-06-03 | $90.89 | 564,600 |
| 2026-06-02 | $90.31 | 336,900 |
| 2026-06-01 | $90.16 | 611,900 |
| 2026-05-29 | $89.38 | 788,000 |
| 2026-05-28 | $90.05 | 614,300 |
| 2026-05-27 | $88.97 | 873,900 |
| 2026-05-26 | $90.14 | 1,069,500 |
About Integer Holdings Corporation
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads. It serves multi-national original equipment manufacturers and affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical markets. The company provides its products under the Greatbatch Medical and the Lake Region Medical brands. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
đ° Latest News
Assessing Integer Holdings (ITGR) Valuation After Recent Share Price Momentum
Simply Wall St. âĸ 2026-06-07T05:10:01Z
Integer Holdings 2026 Outlook: Drivers, Risks, Valuation
Zacks âĸ 2026-06-04T17:52:00Z
Why Is Integra (IART) Up 15% Since Last Earnings Report?
Zacks âĸ 2026-06-04T15:30:17Z
1 Healthcare Stock with Promising Prospects and 2 We Find Risky
StockStory âĸ 2026-06-01T12:08:51Z
3 Cash-Producing Stocks with Questionable Fundamentals
StockStory âĸ 2026-05-21T21:32:55Z
Ares Raises US$30b As It Refocuses On Private Credit And Integer
Simply Wall St. âĸ 2026-05-17T07:15:46Z
Integer Holdings (ITGR): Buy, Sell, or Hold Post Q1 Earnings?
StockStory âĸ 2026-05-17T05:24:55Z
This Medical Device Stock Is Down 25%. One Fund Just Disclosed Buying $5 Million More
Motley Fool âĸ 2026-05-16T17:19:44Z
Ares Management bulks up on credit funds in first quarter of 2026
Reuters âĸ 2026-05-15T22:26:21Z
Why Integer Stock Leaped More Than 5% Higher Today
Motley Fool âĸ 2026-05-13T23:43:21Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,353,251,000 | $1,257,582,000 | $1,145,767,000 | $985,516,000 |
| Cost Of Revenue | $1,353,251,000 | $1,257,582,000 | $1,145,767,000 | $985,516,000 |
| Total Revenue | $1,853,637,000 | $1,716,596,000 | $1,555,656,000 | $1,331,277,000 |
| Operating Revenue | $1,853,637,000 | $1,716,596,000 | $1,555,656,000 | $1,331,277,000 |
| Expenses | ||||
| Interest Expense | $36,324,000 | $52,317,000 | $51,275,000 | $37,265,000 |
| Total Expenses | $1,614,498,000 | $1,496,209,000 | $1,380,905,000 | $1,203,328,000 |
| Other Income Expense | $-71,430,000 | $-16,450,000 | $-18,094,000 | $-22,008,000 |
| Other Non Operating Income Expenses | $-53,212,000 | $-3,521,000 | $-975,000 | $899,000 |
| Net Non Operating Interest Income Expense | $-42,313,000 | $-56,374,000 | $-51,275,000 | $-37,265,000 |
| Total Other Finance Cost | $5,989,000 | $4,057,000 | $3,536,000 | $1,922,000 |
| Interest Expense Non Operating | $36,324,000 | $52,317,000 | $51,275,000 | $37,265,000 |
| Operating Expense | $261,247,000 | $238,627,000 | $235,138,000 | $217,812,000 |
| Other Operating Expenses | - | - | $2,110,000 | $1,188,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $102,830,000 | $121,053,000 | $89,143,000 | $59,747,000 |
| Net Interest Income | $-42,313,000 | $-56,374,000 | $-51,275,000 | $-37,265,000 |
| Normalized Income | $118,219,760 | $131,015,180 | $98,811,088 | $73,032,770 |
| Net Income From Continuing And Discontinued Operation | $102,808,000 | $119,896,000 | $90,650,000 | $66,377,000 |
| Total Operating Income As Reported | $221,264,000 | $208,238,000 | $163,323,000 | $112,678,000 |
| Net Income Common Stockholders | $102,808,000 | $119,896,000 | $90,650,000 | $66,377,000 |
| Net Income | $102,808,000 | $119,896,000 | $90,650,000 | $66,377,000 |
| Net Income Including Noncontrolling Interests | $102,808,000 | $119,896,000 | $90,650,000 | $66,377,000 |
| Net Income Discontinuous Operations | $-22,000 | $-1,157,000 | $1,507,000 | $6,630,000 |
| Net Income Continuous Operations | $102,830,000 | $121,053,000 | $89,143,000 | $59,747,000 |
| Pretax Income | $125,396,000 | $147,563,000 | $105,382,000 | $68,676,000 |
| Special Income Charges | $-18,768,000 | $-12,149,000 | $-11,428,000 | $-15,271,000 |
| Earnings From Equity Interest | $550,000 | $-780,000 | $-5,691,000 | $-7,636,000 |
| Operating Income | $239,139,000 | $220,387,000 | $174,751,000 | $127,949,000 |
| Gross Profit | $500,386,000 | $459,014,000 | $409,889,000 | $345,761,000 |
| Per Share | ||||
| Diluted EPS | $2.89 | $3.36 | $2.69 | $1.99 |
| Basic EPS | $2.96 | $3.57 | $2.72 | $2.00 |
| Other | ||||
| Tax Effect Of Unusual Items | $-3,378,240 | $-2,186,820 | $-1,759,912 | $-1,985,230 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $311,155,000 | $323,060,000 | $266,926,000 | $213,203,000 |
| Total Unusual Items | $-18,768,000 | $-12,149,000 | $-11,428,000 | $-15,271,000 |
| Total Unusual Items Excluding Goodwill | $-18,768,000 | $-12,149,000 | $-11,428,000 | $-15,271,000 |
| Reconciled Depreciation | $130,667,000 | $111,031,000 | $98,841,000 | $91,991,000 |
| EBITDA (Bullshit earnings) | $292,387,000 | $310,911,000 | $255,498,000 | $197,932,000 |
| EBIT | $161,720,000 | $199,880,000 | $156,657,000 | $105,941,000 |
| Diluted Average Shares | $35,594,000 | $35,649,000 | $33,758,000 | $33,357,000 |
| Basic Average Shares | $34,735,000 | $33,601,000 | $33,320,000 | $33,127,000 |
| Diluted NI Availto Com Stockholders | $102,808,000 | $119,896,000 | $90,650,000 | $66,377,000 |
| Tax Provision | $22,566,000 | $26,510,000 | $16,239,000 | $8,929,000 |
| Other Special Charges | $893,000 | - | - | - |
| Restructuring And Mergern Acquisition | $17,875,000 | $12,149,000 | $11,428,000 | $15,271,000 |
| Research And Development | $49,499,000 | $53,425,000 | $61,967,000 | $59,762,000 |
| Selling General And Administration | $211,748,000 | $185,202,000 | $173,171,000 | $158,050,000 |
| Gain On Sale Of Security | - | - | $1,262,000 | $-918,000 |
Fetched: 2026-06-24
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-189,700,000 | $-176,800,000 | $-254,563,000 | $-384,625,000 |
| Total Assets | $3,410,577,000 | $3,077,971,000 | $2,942,653,000 | $2,794,386,000 |
| Total Non Current Assets | $2,640,480,000 | $2,406,852,000 | $2,324,985,000 | $2,236,088,000 |
| Other Non Current Assets | $23,170,000 | $22,959,000 | $58,816,000 | $26,856,000 |
| Non Current Deferred Assets | $8,994,000 | $8,309,000 | $7,001,000 | $6,247,000 |
| Non Current Deferred Taxes Assets | $8,994,000 | $8,309,000 | $7,001,000 | $6,247,000 |
| Goodwill And Other Intangible Assets | $1,936,343,000 | $1,796,015,000 | $1,773,605,000 | $1,802,081,000 |
| Other Intangible Assets | $825,435,000 | $778,286,000 | $779,598,000 | $819,889,000 |
| Current Assets | $770,097,000 | $671,119,000 | $617,668,000 | $558,298,000 |
| Other Current Assets | $40,572,000 | $28,409,000 | $30,033,000 | $27,005,000 |
| Inventory | $253,739,000 | $247,126,000 | $229,102,000 | $208,766,000 |
| Receivables | $458,625,000 | $349,041,000 | $317,154,000 | $298,255,000 |
| Other Receivables | $112,546,000 | $103,772,000 | $85,871,000 | $71,927,000 |
| Accounts Receivable | $346,079,000 | $245,269,000 | $231,283,000 | $224,325,000 |
| Allowance For Doubtful Accounts Receivable | $-600,000 | $-300,000 | $-300,000 | $-300,000 |
| Gross Accounts Receivable | $346,679,000 | $245,569,000 | $231,583,000 | $224,625,000 |
| Cash Cash Equivalents And Short Term Investments | $17,161,000 | $46,543,000 | $23,674,000 | $24,272,000 |
| Cash And Cash Equivalents | $17,161,000 | $46,543,000 | $23,674,000 | $24,272,000 |
| Assets Held For Sale Current | - | $0 | $17,705,000 | - |
| Taxes Receivable | - | - | $1,998,000 | $2,003,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $1,168,018,000 | $943,610,000 | $936,251,000 | $900,989,000 |
| Total Debt | $1,312,598,000 | $1,103,528,000 | $1,052,741,000 | $1,008,771,000 |
| Long Term Debt And Capital Lease Obligation | $1,295,656,000 | $1,081,615,000 | $1,042,323,000 | $979,128,000 |
| Long Term Debt | $1,185,179,000 | $980,153,000 | $959,925,000 | $907,073,000 |
| Current Debt And Capital Lease Obligation | $16,942,000 | $21,913,000 | $10,418,000 | $29,643,000 |
| Current Debt | - | $10,000,000 | - | $18,188,000 |
| Other Current Borrowings | - | $10,000,000 | - | $18,188,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,663,934,000 | $1,458,756,000 | $1,423,611,000 | $1,376,930,000 |
| Total Non Current Liabilities Net Minority Interest | $1,431,893,000 | $1,231,583,000 | $1,202,642,000 | $1,153,178,000 |
| Other Non Current Liabilities | $19,910,000 | $25,360,000 | $14,303,000 | $13,379,000 |
| Non Current Deferred Liabilities | $116,327,000 | $124,608,000 | $143,552,000 | $160,671,000 |
| Non Current Deferred Taxes Liabilities | $116,327,000 | $124,608,000 | $143,552,000 | $160,671,000 |
| Current Liabilities | $232,041,000 | $227,173,000 | $220,969,000 | $223,752,000 |
| Other Current Liabilities | $13,876,000 | $19,017,000 | $12,158,000 | $6,156,000 |
| Current Deferred Liabilities | $5,213,000 | $4,440,000 | $6,142,000 | $5,616,000 |
| Payables And Accrued Expenses | $196,010,000 | $181,803,000 | $192,251,000 | $182,337,000 |
| Interest Payable | $6,442,000 | $4,201,000 | $4,578,000 | $472,000 |
| Payables | $116,378,000 | $104,476,000 | $122,154,000 | $121,703,000 |
| Total Tax Payable | $3,248,000 | $2,978,000 | $3,896,000 | $10,923,000 |
| Income Tax Payable | $3,248,000 | $2,978,000 | $3,896,000 | $10,923,000 |
| Accounts Payable | $113,130,000 | $101,498,000 | $118,258,000 | $110,780,000 |
| Liabilities Heldfor Sale Non Current | - | $0 | $2,464,000 | - |
| Equity | ||||
| Common Stock Equity | $1,746,643,000 | $1,619,215,000 | $1,519,042,000 | $1,417,456,000 |
| Total Equity Gross Minority Interest | $1,746,643,000 | $1,619,215,000 | $1,519,042,000 | $1,417,456,000 |
| Stockholders Equity | $1,746,643,000 | $1,619,215,000 | $1,519,042,000 | $1,417,456,000 |
| Gains Losses Not Affecting Retained Earnings | $58,202,000 | $-14,043,000 | $20,223,000 | $5,329,000 |
| Other Equity Adjustments | $58,202,000 | $-14,043,000 | $20,223,000 | $5,329,000 |
| Retained Earnings | $994,055,000 | $891,247,000 | $771,351,000 | $680,701,000 |
| Other | ||||
| Treasury Shares Number | $1,135,355 | $6 | - | - |
| Ordinary Shares Number | $34,346,450 | $33,546,256 | $33,329,648 | $33,169,778 |
| Share Issued | $35,481,805 | $33,546,262 | $33,329,648 | $33,169,778 |
| Tangible Book Value | $-189,700,000 | $-176,800,000 | $-254,563,000 | $-384,625,000 |
| Invested Capital | $2,931,822,000 | $2,609,368,000 | $2,478,967,000 | $2,342,717,000 |
| Working Capital | $538,056,000 | $443,946,000 | $396,699,000 | $334,546,000 |
| Capital Lease Obligations | $127,419,000 | $113,375,000 | $92,816,000 | $83,510,000 |
| Total Capitalization | $2,931,822,000 | $2,599,368,000 | $2,478,967,000 | $2,324,529,000 |
| Treasury Stock | $76,872,000 | $0 | $0 | - |
| Additional Paid In Capital | $771,223,000 | $741,977,000 | $727,435,000 | $731,393,000 |
| Capital Stock | $35,000 | $34,000 | $33,000 | $33,000 |
| Common Stock | $35,000 | $34,000 | $33,000 | $33,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $110,477,000 | $101,462,000 | $82,398,000 | $72,055,000 |
| Current Deferred Revenue | $5,213,000 | $4,440,000 | $6,142,000 | $5,616,000 |
| Current Capital Lease Obligation | $16,942,000 | $11,913,000 | $10,418,000 | $11,455,000 |
| Current Accrued Expenses | $79,632,000 | $77,327,000 | $70,097,000 | $60,634,000 |
| Goodwill | $1,110,908,000 | $1,017,729,000 | $994,007,000 | $982,192,000 |
| Net PPE | $671,973,000 | $579,569,000 | $485,563,000 | $400,904,000 |
| Accumulated Depreciation | $-569,037,000 | $-502,181,000 | $-451,944,000 | $-438,029,000 |
| Gross PPE | $1,241,010,000 | $1,081,750,000 | $937,507,000 | $838,933,000 |
| Leases | $115,669,000 | $102,988,000 | $90,114,000 | $87,616,000 |
| Construction In Progress | $106,465,000 | $84,891,000 | $147,772,000 | $73,632,000 |
| Other Properties | $137,174,000 | $115,323,000 | $94,386,000 | $85,139,000 |
| Machinery Furniture Equipment | $685,699,000 | $606,765,000 | $506,785,000 | $477,928,000 |
| Buildings And Improvements | $183,504,000 | $159,974,000 | $88,021,000 | $101,445,000 |
| Land And Improvements | $12,499,000 | $11,809,000 | $10,429,000 | $13,173,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $16,141,000 | $15,696,000 | $17,398,000 | $11,938,000 |
| Work In Process | $143,467,000 | $126,810,000 | $102,668,000 | $98,188,000 |
| Raw Materials | $94,131,000 | $104,620,000 | $109,036,000 | $98,640,000 |
Fetched: 2026-06-24
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $105,116,000 | $99,848,000 | $60,275,000 | $41,653,000 |
| Operating Activities | ||||
| Operating Cash Flow | $196,148,000 | $205,205,000 | $180,213,000 | $116,381,000 |
| Cash Flow From Continuing Operating Activities | $196,148,000 | $205,205,000 | $180,213,000 | $116,381,000 |
| Operating Gains Losses | $-550,000 | $780,000 | $5,691,000 | $7,636,000 |
| Investing Activities | ||||
| Capital Expenditure | $-91,032,000 | $-105,357,000 | $-119,938,000 | $-74,728,000 |
| Investing Cash Flow | $-270,731,000 | $-195,414,000 | $-163,367,000 | $-200,421,000 |
| Cash From Discontinued Investing Activities | $-950,000 | $48,698,000 | $0 | $0 |
| Cash Flow From Continuing Investing Activities | $-269,781,000 | $-244,112,000 | $-163,367,000 | $-200,421,000 |
| Net Other Investing Changes | $123,000 | $-211,000 | $173,000 | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-50,014,000 | $0 | $0 | - |
| Financing Cash Flow | $43,558,000 | $13,321,000 | $-18,014,000 | $92,476,000 |
| Cash Flow From Continuing Financing Activities | $43,558,000 | $13,321,000 | $-18,014,000 | $92,476,000 |
| Net Other Financing Charges | $-87,938,000 | $-3,692,000 | $-47,749,000 | $-2,582,000 |
| Net Common Stock Issuance | $-50,014,000 | $0 | $0 | - |
| Other | ||||
| Repayment Of Debt | $-1,106,634,000 | $-258,229,000 | $-841,921,000 | $-71,092,000 |
| Issuance Of Debt | $1,284,500,000 | $274,500,000 | $869,353,000 | $166,000,000 |
| Interest Paid Supplemental Data | $32,407,000 | $54,167,000 | $37,701,000 | $35,804,000 |
| Income Tax Paid Supplemental Data | $28,220,000 | $36,472,000 | $30,351,000 | $11,165,000 |
| End Cash Position | $17,161,000 | $46,543,000 | $23,674,000 | $24,272,000 |
| Beginning Cash Position | $46,543,000 | $23,674,000 | $24,272,000 | $17,885,000 |
| Effect Of Exchange Rate Changes | $1,643,000 | $-243,000 | $570,000 | $-2,049,000 |
| Changes In Cash | $-31,025,000 | $23,112,000 | $-1,168,000 | $8,436,000 |
| Proceeds From Stock Option Exercised | $3,644,000 | $742,000 | $2,303,000 | $150,000 |
| Common Stock Payments | $-50,014,000 | $0 | $0 | - |
| Net Issuance Payments Of Debt | $177,866,000 | $16,271,000 | $27,432,000 | $94,908,000 |
| Net Long Term Debt Issuance | $177,866,000 | $16,271,000 | $27,432,000 | $94,908,000 |
| Long Term Debt Payments | $-1,106,634,000 | $-258,229,000 | $-841,921,000 | $-71,092,000 |
| Long Term Debt Issuance | $1,284,500,000 | $274,500,000 | $869,353,000 | $166,000,000 |
| Net Business Purchase And Sale | $-178,872,000 | $-138,544,000 | $-43,602,000 | $-126,636,000 |
| Purchase Of Business | $-178,872,000 | $-138,544,000 | $-43,602,000 | $-126,636,000 |
| Net PPE Purchase And Sale | $-91,032,000 | $-105,357,000 | $-119,938,000 | $-74,089,000 |
| Purchase Of PPE | $-91,032,000 | $-105,357,000 | $-119,938,000 | $-74,728,000 |
| Change In Working Capital | $-120,418,000 | $-54,624,000 | $-52,297,000 | $-75,847,000 |
| Change In Payables And Accrued Expense | $-25,688,000 | $-11,337,000 | $-106,000 | $29,033,000 |
| Change In Accrued Expense | $-20,269,000 | $4,472,000 | $7,908,000 | $-9,529,000 |
| Change In Payable | $-5,419,000 | $-15,809,000 | $-8,014,000 | $38,562,000 |
| Change In Account Payable | $-566,000 | $-16,620,000 | $-520,000 | $26,038,000 |
| Change In Tax Payable | $-4,853,000 | $811,000 | $-7,494,000 | $12,524,000 |
| Change In Income Tax Payable | $-4,853,000 | $811,000 | $-7,494,000 | $12,524,000 |
| Change In Prepaid Assets | $-2,495,000 | $-229,000 | $-930,000 | $764,000 |
| Change In Inventory | $-2,576,000 | $-18,079,000 | $-30,178,000 | $-56,721,000 |
| Change In Receivables | $-89,659,000 | $-24,979,000 | $-21,083,000 | $-48,923,000 |
| Changes In Account Receivables | $-82,382,000 | $-6,532,000 | $-7,437,000 | $-41,380,000 |
| Other Non Cash Items | $63,104,000 | $17,465,000 | $23,535,000 | $22,699,000 |
| Stock Based Compensation | $23,224,000 | $24,767,000 | $23,283,000 | $21,023,000 |
| Deferred Tax | $-2,687,000 | $-14,110,000 | $-9,490,000 | $-17,498,000 |
| Deferred Income Tax | $-2,687,000 | $-14,110,000 | $-9,490,000 | $-17,498,000 |
| Depreciation Amortization Depletion | $130,667,000 | $111,031,000 | $98,841,000 | $91,991,000 |
| Depreciation And Amortization | $130,667,000 | $111,031,000 | $98,841,000 | $91,991,000 |
| Earnings Losses From Equity Investments | $-550,000 | $780,000 | $5,691,000 | $7,636,000 |
| Net Income From Continuing Operations | $102,808,000 | $119,896,000 | $90,650,000 | $66,377,000 |
| Net Investment Purchase And Sale | - | $0 | $0 | $304,000 |
| Sale Of Investment | - | $0 | $0 | $304,000 |
| Net Intangibles Purchase And Sale | - | $-250,000 | $0 | $0 |
| Purchase Of Intangibles | - | $-250,000 | $0 | $0 |
| Sale Of PPE | - | $39,000 | $173,000 | $639,000 |
| Net Short Term Debt Issuance | - | - | - | - |
| Short Term Debt Payments | - | - | - | - |
| Short Term Debt Issuance | - | - | - | - |
Fetched: 2026-06-24